Local Institution
Mobile, Alabama 36604
0 studies enrolling now · 10 studies all time
What they study most
Arthritis, Rheumatoid, Diabetes Mellitus, Metabolics Diabetes Nos, Non-Small-Cell Lung Carcinoma, Pulmonary Embolism, Rheumatoid Arthritis, Stage III (Unresectable) or Stage IV Advanced Melanoma, Type 2 Diabetes, Venous Thrombosis
Studies at this site
- A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus — Completed
- Expanded Access Program With Nivolumab to Treat Melanoma — NO_LONGER_AVAILABLE
- Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
- Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed
- Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients — Completed
- PPAR - Combination With Metformin — Completed
- A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate — Completed
- Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past. — Completed
- PPAR-COMBO With Sulfonylurea — Completed
- BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery — Completed